A scientific morning about Eplerenone safety over Spironolactone according to the latest Heart failure Guidelines and articles was held on Monday, February 6, 1401, at
A scientific morning about gout and its treatment methods was held on Wednesday, December 16, 1401 in the rheumatology department of Imam Khomeini Hospital in
A scientific morning was held in the Rheumatology Department of Loqman Hakim Hospital in Tehran by Kimiaara Company on Sunday, 20th December 1401. In this
A scientific morning related to gout disease and its prevalence in Iran and the world was held on December 24, 1401 in the department of
A scientific morning with subject of “pain” was held at Imam Hossein Hospital in Tehran on Saturday, December 17th, 2022, by Kimiaara company. This morning
The most professional and unique aesthetic workshop with subject of “Advanced face contouring centered with combination therapies” has been held by Kimiara sponsorship with presentation
Scientific session of the Department of Cardiology of Rasoul akram Hospital on effect of the superiority of eplerenone molecule over spironolactone in the treatment of
saypha training workshop was held on september 23, 2022 at Iranian Clinic in Tehran, with the presence of Tehran beauty physicians and dermatologists. Furthermore to
Scientific meeting (advisory board) of Kimiara company regarding the position of Lepronzo (eplerenone 25 and 50) in the treatment of heart failure and hypertension on
Scientific meeting of Kerman’s cardiologists sponsored by Kimiara company Subject: The effects of antiplatelet drugs in the treatment of Acute and Chronic Coronary Syndrome and
Kimiara Pharmaceutical Company was established in 2005 as one of the subsidiaries of Ahran Tejarat Group.
All rights of this website belong to Kimiara Company. © 2022
